Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease

Gastroenterology. 2003 Aug;125(2):637-8. doi: 10.1016/s0016-5085(03)00983-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / prevention & control*
  • Isoenzymes / antagonists & inhibitors*
  • Lactones / therapeutic use*
  • Longitudinal Studies
  • Membrane Proteins
  • Middle Aged
  • Prospective Studies
  • Prostaglandin-Endoperoxide Synthases
  • Recurrence
  • Sulfones

Substances

  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Lactones
  • Membrane Proteins
  • Sulfones
  • rofecoxib
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases